Operating Income: The income after operating expenses.
NexImmune, Inc. (NEXI) had Operating Income of $-2.76M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-3.08M |
|
-- |
|
-- |
|
$2.76M |
|
|
Operating Income |
$-2.76M |
$-0.32M |
|
$-3.08M |
|
$-3.08M |
|
$-3.08M |
|
$-3.08M |
|
$-3.08M |
|
$-3.08M |
|
$-2.76M |
|
$-2.64M |
|
1.25M |
|
1.25M |
|
$-2.46 |
|
$-2.46 |
|
| Balance Sheet Financials | |
$6.04M |
|
$1.24M |
|
$2.95M |
|
$8.99M |
|
$4.63M |
|
-- |
|
$1.61M |
|
$6.25M |
|
$2.74M |
|
$2.74M |
|
$2.74M |
|
1.37M |
|
| Cash Flow Statement Financials | |
$-2.42M |
|
$0.52M |
|
$3.14M |
|
$3.22M |
|
$4.47M |
|
$1.25M |
|
$0.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-112.20% |
|
-112.20% |
|
-34.23% |
|
-112.20% |
|
$2.00 |
|
$-1.51 |
|
$-1.93 |
|